VedTechBio Research Pvt. Ltd., a pioneer in AI-driven drug discovery, today announced major enhancements to its RxAgentAI™ platform cutting drug discovery timelines in half alongside a strategic ...

In 2025, sales are anticipated to grow by a high single-digit percentage at CER (previously mid-to-high single-digit). Sanofi confirms the expectation of a strong business EPS rebound with growth at a ...

Proof-of-concept studies ongoing in lupus nephritis (LN), systemic sclerosis (SSc) and antibody mediated rejection (AMR); topline results expected for LN in fourth quarter of 2025, SSc in second half ...

Le 23 juillet 2025, Ipsen a reçu l’approbation de la Commission européenne pour Cabometyx ® (cabozantinib) dans les tumeurs neuroendocrines avancées préalablement traitées. Cette approbation repose ...

Ipsen intends to publish its year-to-date and third-quarter sales update on 22 October 2025.

Fagron delivers strong performance with 11% topline growth and 12% increase in REBITDA for H1 2025 Fagron, the leading global player in pharmaceutical compounding today publishes its first half ...

Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the second quarter and first half year ended June ...

Closing of the private placement and the debt settlement is subject to customary closing conditions and the Company intends to close as soon as practicable. All of the securities will be subject to a ...

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of an underwritten ...

Wherley brings nearly a decade of executive leadership at VITAS to his new role. He has served as chief operating officer for the past eight years and assumed the role of president in 2024, overseeing ...

Lytus Fintech, a business unit of Lytus Technologies Holdings PTV Ltd. (OTCMKTS: LYTHF) today announced the launch of its integration and support of XRP with its flagship digital wallet platform NexFi ...

CrazyBulk has long been recognized as a leader in natural, legal performance supplements. In 2025, the brand has solidified ...